-
1
-
-
77949441790
-
Developing a global agenda for sickle cell disease: Report of an international symposium and workshop in Cotonou, Republic of Benin
-
Odame I. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin. Am J Prev Med 2010; 38 (4 Suppl):S571-S575.
-
(2010)
Am J Prev Med
, vol.38
, Issue.4 SUPPL.
-
-
Odame, I.1
-
2
-
-
77949482609
-
Population estimates of sickle cell disease in the U.S
-
Hassell KL Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010; 38 (4 Suppl):S512-S521.
-
(2010)
Am J Prev Med
, vol.38
, Issue.4 SUPPL.
-
-
Hassell, K.L.1
-
3
-
-
0001700270
-
Hereditary persistence of fetal hemoglobin: A study of 79 affected persons in 15 Negro families in Baltimore
-
Conley CL, Weatherall DJ, Richardson SN, et al. Hereditary persistence of fetal hemoglobin: a study of 79 affected persons in 15 Negro families in Baltimore. Blood 1963; 21:261-281.
-
(1963)
Blood
, vol.21
, pp. 261-281
-
-
Conley, C.L.1
Weatherall, D.J.2
Richardson, S.N.3
-
4
-
-
0025653912
-
Fetal hemoglobin, sickling, and sickle cell disease
-
Charache S. Fetal hemoglobin, sickling, and sickle cell disease. Adv Pediatr 1990; 37:1-31.
-
(1990)
Adv Pediatr
, vol.37
, pp. 1-31
-
-
Charache, S.1
-
5
-
-
0021286875
-
Hydroxyurea enhanced fetal hemoglobin production in sickle cell anemia
-
Platt OS, Orkin SH, Dover G, et al. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 1984; 74:652-656. (Pubitemid 14054015)
-
(1984)
Journal of Clinical Investigation
, vol.74
, Issue.2
, pp. 652-656
-
-
Platt, O.S.1
Orkin, S.H.2
Dover, G.3
-
6
-
-
0028913012
-
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis
-
Cortelazzo S, Finazzi G, Ruggeri M, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995; 332:1132-1136.
-
(1995)
N Engl J Med
, vol.332
, pp. 1132-1136
-
-
Cortelazzo, S.1
Finazzi, G.2
Ruggeri, M.3
-
8
-
-
0014023973
-
Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia
-
Kennedy BJ, Yarbro JW. Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia. J Am Med Assoc 1966; 195:1038-1043.
-
(1966)
J Am Med Assoc
, vol.195
, pp. 1038-1043
-
-
Kennedy, B.J.1
Yarbro, J.W.2
-
9
-
-
0027948936
-
Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication
-
Lori F, Malykh A, Cara A, et al. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science 1994; 266:801-805. (Pubitemid 24359288)
-
(1994)
Science
, vol.266
, Issue.5186
, pp. 801-805
-
-
Lori, F.1
Malykh, A.2
Cara, A.3
Sun, D.4
Weinstein, J.N.5
Lisziewicz, J.6
Gallo, R.C.7
-
10
-
-
0014409894
-
Effect of hydroxyurea on ribonucleotide reductase
-
Elford HL Effect of hydroxyurea on ribonucleotide reductase. Biochem Biophys Res Commun 1968; 33:129-135.
-
(1968)
Biochem Biophys Res Commun
, vol.33
, pp. 129-135
-
-
Elford, H.L.1
-
11
-
-
0026631318
-
Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia
-
Charache S, Dover GJ, Moore RD, et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992; 79:2555-2565.
-
(1992)
Blood
, vol.79
, pp. 2555-2565
-
-
Charache, S.1
Dover, G.J.2
Moore, R.D.3
-
12
-
-
13044277572
-
Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial
-
Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999; 94:1550-1554. (Pubitemid 29411304)
-
(1999)
Blood
, vol.94
, Issue.5
, pp. 1550-1554
-
-
Kinney, T.R.1
Helms, R.W.2
O'Branski, E.E.3
Ohene-Frempong, K.4
Wang, W.5
Daeschner, C.6
Vichinsky, E.7
Redding-Lallinger, R.8
Gee, B.9
Platt, O.S.10
Ware, R.E.11
-
13
-
-
63649117820
-
A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia
-
Thornburg CD, Dixon N, Burgett S, et al. A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatr Blood Cancer 2009; 52:609-615.
-
(2009)
Pediatr Blood Cancer
, vol.52
, pp. 609-615
-
-
Thornburg, C.D.1
Dixon, N.2
Burgett, S.3
-
14
-
-
27144448031
-
Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study
-
DOI 10.1182/blood-2004-12-4973
-
Hankins JS, Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood 2005; 106:2269-2275. (Pubitemid 41510795)
-
(2005)
Blood
, vol.106
, Issue.7
, pp. 2269-2275
-
-
Hankins, J.S.1
Ware, R.E.2
Rogers, Z.R.3
Wynn, L.W.4
Lane, P.A.5
Scott, J.P.6
Wang, W.C.7
-
15
-
-
79954999874
-
Hydroxyurea treatment of infants with sickle cell anemia: Results of the BABY HUG study
-
ASPHO Annual Meeting Abstract
-
Wang W, Thompson B. Hydroxyurea treatment of infants with sickle cell anemia: results of the BABY HUG study. ASPHO Annual Meeting Abstract. Pediatr Blood Cancer 2010; 54:787.
-
(2010)
Pediatr Blood Cancer
, vol.54
, pp. 787
-
-
Wang, W.1
Thompson, B.2
-
16
-
-
49349104104
-
A cell stress signaling model of fetal hemoglobin induction; What doesn't kill red blood cells makes them stronger
-
Mabaera R, West RJ, Conine SJ, et al. A cell stress signaling model of fetal hemoglobin induction; what doesn't kill red blood cells makes them stronger. Exp Hematol 2008; 36:1057-1072.
-
(2008)
Exp Hematol
, vol.36
, pp. 1057-1072
-
-
Mabaera, R.1
West, R.J.2
Conine, S.J.3
-
17
-
-
0037237980
-
Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase
-
DOI 10.1172/JCI200316672
-
Cokic VP, Smith RD, Beleslin-Cokic BB, et al. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest 2003; 111:231-239. (Pubitemid 36105922)
-
(2003)
Journal of Clinical Investigation
, vol.111
, Issue.2
, pp. 231-239
-
-
Cokic, V.P.1
Smith, R.D.2
Beleslin-Cokic, B.B.3
Njoroge, J.M.4
Miller, J.L.5
Gladwin, M.T.6
Schechter, A.N.7
-
18
-
-
38949192565
-
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
-
DOI 10.1182/blood-2007-05-088732
-
Cokic VP, Andric SA, Stojilkovic SS, et al. Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells. Blood 2008; 111:111 7-1123. (Pubitemid 351213390)
-
(2008)
Blood
, vol.111
, Issue.3
, pp. 1117-1123
-
-
Cokic, V.P.1
Andric, S.A.2
Stojilkovic, S.S.3
Noguchi, C.T.4
Schechter, A.N.5
-
20
-
-
77955905049
-
How i use hydroxyurea to treat young patients with sickle cell anemia
-
Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 2010; 115:5300-5311.
-
(2010)
Blood
, vol.115
, pp. 5300-5311
-
-
Ware, R.E.1
-
21
-
-
74749106742
-
Hydroxyurea for children with sickle cell disease
-
Heeney MM, Ware RE. Hydroxyurea for children with sickle cell disease. Hematol Oncol Clin North Am 2010; 24:199-214.
-
(2010)
Hematol Oncol Clin North Am
, vol.24
, pp. 199-214
-
-
Heeney, M.M.1
Ware, R.E.2
-
22
-
-
0037414164
-
Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits Up to 9 Years of Treatment
-
DOI 10.1001/jama.289.13.1645
-
Steinberg MH, Barton F, Castro O, etal. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. J Am Med Assoc 2003; 289:1645-1651. (Pubitemid 37430269)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.13
, pp. 1645-1651
-
-
Steinberg, M.H.1
Barton, F.2
Castro, O.3
Pegelow, C.H.4
Ballas, S.K.5
Kutlar, A.6
Orringer, E.7
Bellevue, R.8
Olivieri, N.9
Eckman, J.10
Varma, M.11
Ramirez, G.12
Adler, B.13
Smith, W.14
Carlos, T.15
Ataga, K.16
DeCastro, L.17
Bigelow, C.18
Saunthararajah, Y.19
Telfer, M.20
Vichinsky, E.21
Claster, S.22
Shurin, S.23
Bridges, K.24
Waclawiw, M.25
Bonds, D.26
Terrin, M.27
more..
-
23
-
-
1542373662
-
Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease
-
DOI 10.1182/blood-2003-07-2475
-
Zimmerman SA, Schultz WH, Davis JS, et al. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 2004; 103:2039-2045. (Pubitemid 38326218)
-
(2004)
Blood
, vol.103
, Issue.6
, pp. 2039-2045
-
-
Zimmerman, S.A.1
Schultz, W.H.2
Davis, J.S.3
Pickens, C.V.4
Mortier, N.A.5
Howard, T.A.6
Ware, R.E.7
-
24
-
-
0029845949
-
Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial
-
Ferster A, Vermylen C, Cornu G, et al. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 1996; 88:1960-1964. (Pubitemid 26307897)
-
(1996)
Blood
, vol.88
, Issue.6
, pp. 1960-1964
-
-
Ferster, A.1
Vermylen, C.2
Cornu, G.3
Buyse, M.4
Corazza, F.5
Devalck, C.6
Fondu, P.7
Toppet, M.8
Sariban, E.9
-
25
-
-
77950622293
-
The effect of prolonged admin-istration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: Results of a 17-year, single-centertrial (LaSHS)
-
Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged admin-istration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-centertrial (LaSHS). Blood 2010; 115:2354-2363.
-
(2010)
Blood
, vol.115
, pp. 2354-2363
-
-
Voskaridou, E.1
Christoulas, D.2
Bilalis, A.3
-
26
-
-
0029025475
-
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
-
Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332:131 7-1322.
-
(1995)
N Engl J Med
, vol.332
, pp. 1317-1322
-
-
Charache, S.1
Terrin, M.L.2
Moore, R.D.3
-
27
-
-
45549105597
-
Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease
-
Lanzkron S, Strouse JJ, Wilson R, etal. Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 2008; 148:939-955. (Pubitemid 351860826)
-
(2008)
Annals of Internal Medicine
, vol.148
, Issue.12
, pp. 939-955
-
-
Lanzkron, S.1
Strouse, J.J.2
Wilson, R.3
Beach, M.C.4
Haywood, C.5
Park, H.6
Witkop, C.7
Bass, E.B.8
Segal, J.B.9
-
28
-
-
58249093004
-
Hydroxyurea for sickle cell disease: A systematic review for efficacy and toxicity in children
-
Strouse JJ, Lanzkron S, Beach MC, etal. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics 2008; 122:1332-1342.
-
(2008)
Pediatrics
, vol.122
, pp. 1332-1342
-
-
Strouse, J.J.1
Lanzkron, S.2
Beach, M.C.3
-
29
-
-
45549101008
-
National Institutes of Health Consensus Development Conference statement: Hydroxyurea treatment for sickle cell disease
-
Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med 2008; 148:932-938. (Pubitemid 351860825)
-
(2008)
Annals of Internal Medicine
, vol.148
, Issue.12
, pp. 932-938
-
-
Brawley, O.W.1
Cornelius, L.J.2
Edwards, L.R.3
Northington Gamble, V.4
Green, B.L.5
Inturrisi, C.6
James, A.H.7
Laraque, D.8
Mendez, M.9
Montoya, C.J.10
Pollock, B.H.11
Robinson, L.12
Scholnik, A.P.13
Schori, M.14
-
30
-
-
74849091075
-
The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design
-
Thompson BW, Miller ST, Rogers ZR, etal. The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design. Pediatr Blood Cancer 2010; 54:250-255.
-
(2010)
Pediatr Blood Cancer
, vol.54
, pp. 250-255
-
-
Thompson, B.W.1
Miller, S.T.2
Rogers, Z.R.3
-
31
-
-
27944496081
-
Outcome of sickle cell anemia: A 4-decade observational study of 1056 patients
-
DOI 10.1097/01.md.0000189089.45003.52
-
Powars DR, Chan LS, Hiti A, etal. Outcome of sickle cell anemia: a4-decade observational study of 1056 patients. Medicine 2005; 84:363-376. (Pubitemid 41668935)
-
(2005)
Medicine
, vol.84
, Issue.6
, pp. 363-376
-
-
Powars, D.R.1
Chan, L.S.2
Hiti, A.3
Ramicone, E.4
Johnson, C.5
-
32
-
-
0028291736
-
Mortality in sickle cell disease: Life expectancy and risk factors for early death
-
Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994; 330:1639-1644.
-
(1994)
N Engl J Med
, vol.330
, pp. 1639-1644
-
-
Platt, O.S.1
Brambilla, D.J.2
Rosse, W.F.3
-
33
-
-
37549007933
-
Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea
-
Hankins JS, Helton KJ, McCarville MB, et al. Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Pediatr Blood Cancer 2008; 50:293-297.
-
(2008)
Pediatr Blood Cancer
, vol.50
, pp. 293-297
-
-
Hankins, J.S.1
Helton, K.J.2
McCarville, M.B.3
-
34
-
-
34547961356
-
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia
-
DOI 10.1182/blood-2006-11-057893
-
Zimmerman SA, Schultz WH, Burgett S, et al. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood 2007; 110:1043-1047. (Pubitemid 47267446)
-
(2007)
Blood
, vol.110
, Issue.3
, pp. 1043-1047
-
-
Zimmerman, S.A.1
Schultz, W.H.2
Burgett, S.3
Mortier, N.A.4
Ware, R.E.5
-
36
-
-
0021933164
-
Developmental pattern of splenic dysfunction in sickle cell disorders
-
Pearson HA, Gallagher D, Chilcote R, et al. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics 1985; 76:392-397. (Pubitemid 15242503)
-
(1985)
Pediatrics
, vol.76
, Issue.3
, pp. 392-397
-
-
Pearson, H.A.1
Gallagher, D.2
Chilcote, R.3
-
37
-
-
50549162474
-
A comparative study of renal concentrating ability in children with sickle cell anemia and in normal children
-
Whitten CF, Younes AA. A comparative study of renal concentrating ability in children with sickle cell anemia and in normal children. J Lab Clin Med 1960; 55:400-415.
-
(1960)
J Lab Clin Med
, vol.55
, pp. 400-415
-
-
Whitten, C.F.1
Younes, A.A.2
-
38
-
-
72049092388
-
Renal function in infants with sickle cell anemia: Baseline data from the BABY HUG trial
-
Ware RE, Rees RC, Sarnaik SA, et al. Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. J Pediatr 2010; 156:66-70.
-
(2010)
J Pediatr
, vol.156
, pp. 66-70
-
-
Ware, R.E.1
Rees, R.C.2
Sarnaik, S.A.3
-
39
-
-
0025355908
-
Renal abnormalities in sickle cell disease
-
DOI 10.1001/archinte.150.3.501
-
Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med 1990; 150:501-504. (Pubitemid 20122000)
-
(1990)
Archives of Internal Medicine
, vol.150
, Issue.3
, pp. 501-504
-
-
Allon, M.1
-
40
-
-
0034105690
-
Renal abnormalities in sickle cell disease
-
Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol 2000; 63:205-221.
-
(2000)
Am J Hematol
, vol.63
, pp. 205-221
-
-
Ataga, K.I.1
Orringer, E.P.2
-
41
-
-
77953057530
-
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
-
Steinberg MH, McCarthy WF, Castro O, et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol 2010; 85:403-408.
-
(2010)
Am J Hematol
, vol.85
, pp. 403-408
-
-
Steinberg, M.H.1
McCarthy, W.F.2
Castro, O.3
-
42
-
-
80855145623
-
Hydroxyurea therapy reduces mortality among children with sickle cell disease ASH Annual Meeting Abstracts
-
Lobo C, Hankins JS, Moura P, Pinto JC. Hydroxyurea therapy reduces mortality among children with sickle cell disease. ASH Annual Meeting Abstracts. Blood 2010; 116:843a.
-
(2010)
Blood
, vol.116
-
-
Lobo, C.1
Hankins, J.S.2
Moura, P.3
Pinto, J.C.4
-
43
-
-
0031846124
-
Leg ulcers associated with long-term hydroxyurea therapy
-
Weinlich G, Schuler G, Greil R, et al. Leg ulcers associated with long-term hydroxyurea therapy. J Am Acad Dermatol 1998; 39:372-374. (Pubitemid 28367320)
-
(1998)
Journal of the American Academy of Dermatology
, vol.39
, Issue.2
, pp. 372-374
-
-
Weinlich, G.1
Schuler, G.2
Greil, R.3
Kofler, H.4
Fritsch, P.5
-
44
-
-
0013793439
-
Induction of chromosome breaks in cultured normal human leukocytes by potassium arsenite, hydroxyurea and related compounds
-
Oppenheim JJ, Fishbein WN. Induction of chromosome breaks in cultured normal human leukocytes by potassium arsenite, hydroxyurea and related compounds. Cancer Res 1965; 25:980-985.
-
(1965)
Cancer Res
, vol.25
, pp. 980-985
-
-
Oppenheim, J.J.1
Fishbein, W.N.2
-
45
-
-
0022392453
-
Microsome- and hepatocyte-mediated mutagenicity of hydroxyurea and related aliphatic hydroxamic acids in V79 Chinese hamster cells
-
Ziegler-Skylakakis K, Schwarz LR, Andrae U. Microsome-and hepatocyte-mediated mutagenicity of hydroxyurea and related aliphatic hydroxamic acids in V79 Chinese hamster cells. Mutat Res 1985; 152 (2-3):225-231. (Pubitemid 16198555)
-
(1985)
Mutation Research
, vol.152
, Issue.2-3
, pp. 225-231
-
-
Ziegler-Skylakakis, K.1
Schwarz, L.R.2
Andrae, U.3
-
46
-
-
0007088448
-
Preliminary survey of hydroxyurea (Nsc-32065) as a teratogen
-
Murphy ML, Chaube S. Preliminary survey of hydroxyurea (Nsc-32065) as a teratogen. Cancer Chemother Rep 1964; 40:1-7.
-
(1964)
Cancer Chemother Rep
, vol.40
, pp. 1-7
-
-
Murphy, M.L.1
Chaube, S.2
-
47
-
-
0035206628
-
Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide
-
Sakano K, Oikawa S, Hasegawa K, Kawanishi S. Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide. Jpn J Cancer Res 2001; 92:1166-1174. (Pubitemid 33133485)
-
(2001)
Japanese Journal of Cancer Research
, vol.92
, Issue.11
, pp. 1166-1174
-
-
Sakano, K.1
Oikawa, S.2
Hasegawa, K.3
Kawanishi, S.4
-
48
-
-
0035383785
-
Five years of experience with hydroxyurea in children and young adults with sickle cell disease
-
Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001; 97:3628-3632.
-
(2001)
Blood
, vol.97
, pp. 3628-3632
-
-
Ferster, A.1
Tahriri, P.2
Vermylen, C.3
-
49
-
-
77954934323
-
Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia
-
Flanagan JM, Howard TA, Mortier N, et al. Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia. Mutat Res 2010; 698:38-42.
-
(2010)
Mutat Res
, vol.698
, pp. 38-42
-
-
Flanagan, J.M.1
Howard, T.A.2
Mortier, N.3
-
50
-
-
79955001744
-
Chromosome damage and repair in children with sickle cell anemia and long-term hydroxyurea exposure
-
ASPHO Annual Meeting Abstract press
-
McGann PT, Howard TA, Flanagan JM, et al. Chromosome damage and repair in children with sickle cell anemia and long-term hydroxyurea exposure. ASPHO Annual Meeting Abstract. Pediatr Blood Cancer (in press).
-
Pediatr Blood Cancer
-
-
McGann, P.T.1
Howard, T.A.2
Flanagan, J.M.3
-
51
-
-
79955005753
-
From infancy to adolescence: Over a decade of continuous hydroxyurea therapy in sickle cell anemia
-
ASPHO Annual Meeting Abstract
-
Hankins JS, Aygun B, Wang W, et al. From infancy to adolescence: over a decade of continuous hydroxyurea therapy in sickle cell anemia. ASPHO Annual Meeting Abstract. Pediatr Blood Cancer 2010; 54:790.
-
(2010)
Pediatr Blood Cancer
, vol.54
, pp. 790
-
-
Hankins, J.S.1
Aygun, B.2
Wang, W.3
-
52
-
-
77953952024
-
The inherited diseases of hemoglobin are an emerging global health burden
-
Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010; 115:4331-4336.
-
(2010)
Blood
, vol.115
, pp. 4331-4336
-
-
Weatherall, D.J.1
-
53
-
-
77951712618
-
Improved survival of children and adolescents with sickle cell disease
-
Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood 2010; 115:3447-3452.
-
(2010)
Blood
, vol.115
, pp. 3447-3452
-
-
Quinn, C.T.1
Rogers, Z.R.2
McCavit, T.L.3
Buchanan, G.R.4
-
54
-
-
12844276479
-
A case for developing North-South partnerships for research in sickle cell disease
-
DOI 10.1182/blood-2004-06-2404
-
Weatherall D, Hofman K, Rodgers G, et al. A case for developing North-South partnerships for research in sickle cell disease. Blood 2005; 105:921-923. (Pubitemid 40170855)
-
(2005)
Blood
, vol.105
, Issue.3
, pp. 921-923
-
-
Weatherall, D.1
Hofman, K.2
Rodgers, G.3
Ruffin, J.4
Hrynkow, S.5
|